Bionix Development Co. Appoints Dorian Drake International Inc. as Export Sales Representative
White Plains, New York -- Bionix Development Corporation, a leader in the development, manufacturing and marketing of innovative medical devices and equipment, has appointed Dorian Drake International Inc. as its export sales representative for its Medical Technologies products division in select Latin American and Caribbean markets.
Dorian Drake will act as Bionix’s sales and marketing arm in its sales territories, with special focus on building brand recognition and distribution in each market.
“We are delighted to have the opportunity to form a new partnership with Dorian Drake,” said Chad Gottschalk, International Account Manager for the Bionix Development Corporation. “Our goal is to align our innovative medical device portfolio together with the expertise of Dorian Drake in their target markets. We are hopeful that this collaboration will bring new opportunities for healthcare professionals to provide their patients with the highest level of care.”
Commenting on the new arrangement, Dorian Drake’s President, Ed Dorian Jr. said, “Bionix stands apart from many of its competitors in product quality, design and innovation in the areas of ear care, nutrition & feeding, nasal care, NICU care, and pain relief. We look forward to working with Chad and his team to build Bionix sales in Latin America and the Caribbean.
About Bionix Development Corporation, Medical Devices and Equipment
For over 30 years, Bionix Medical Technologies has been a leader in the development, manufacturing and marketing of innovative medical devices and equipment for ear care, nutrition & feeding, nasal care, NICU care, and pain relief. Bionix focuses on helping physicians and allied health professionals meet the high-pressure demands of a constantly changing health care environment. To learn more, go to www.Bionix.com.
About Dorian Drake International, an Export Management Company (EMC)
Based in White Plains, N.Y., Dorian Drake International is an export management company that manages international sales, marketing, customer service, traffic, credit and collections for manufacturers selling in markets outside the United States. The firm staffs stand-alone sales teams in five distinct industries: automotive; foodservice equipment; hardware and lawn and garden; industrial and environmental, and medical.
Related news
-
SeqOne Genomics closes €20M series A to accelerate the deployment of its genomic medicine platform
The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in cancer and hereditary disease. The company will intensify investments in the development of its genomic-aware data lake to...
-
Daxor Corporation to Commence Trading on the Nasdaq Capital Market
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The Nasdaq Capital Market effective at the opening of trading on February 2, 2022, transferring the listing of its common stock from the New York Stock Exchange – American. Daxor’s common stock will continue trading under the ticker symbol “DXR” after the transfer. The Company’s common stock will continue to trade on the NYSE American until the...
-
The Indoor Microbiome and Its Impact on Indoor Environmental Quality
Last year, the U.S. Environmental Protection Agency (EPA) announced the release of a new webpage to provide information about the indoor microbiome. All of the living microorganisms inside of an indoor environment, and their by-products, are collectively known as the indoor microbiome. The indoor microbiome that surrounds each of us is diverse and dynamic, made up of bacteria, viruses, fungi and other single-celled organisms. These microorganisms may be growing or inactive, and may be present in different life...
-
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh will present a corporate overview at the H.C. Wainwright BioConnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022. Mr. Feldshuh will provide company updates and key highlights, including a new patent award and progress with BVA-100® next generation development. The presentation will be available on-demand beginning at 7:00 a.m. ET...
-
Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces patient enrollment is complete and data analysis is underway in preparation for publication of the multi-center observational prospective study utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology in hospitalized COVID-19 patients. NYU Langone Health, Wake Forest School of Medicine and OHSU have been enrolling subjects since the onset of the pandemic. Dr. Jan Bakker, MD,...
Customer comments
No comments were found for Bionix Development Co. Appoints Dorian Drake International Inc. as Export Sales Representative. Be the first to comment!